These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6827693)

  • 21. Clinical urodynamics in neurogenic bladder dysfunction.
    Thomas D
    Urol Clin North Am; 1979 Feb; 6(1):237-53. PubMed ID: 432993
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical cardiac electrophysiological assessment of indoramin.
    Butrous GS; Camm AJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S137-43. PubMed ID: 2423787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vesicourethral pressure recordings in the assessment of neurogenic bladder functions in spinal cord injury patients.
    Yalla SV; Rossier AB; Fam B
    Urol Int; 1977; 32(2-3):161-75. PubMed ID: 906180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A trial of an alpha-adrenoreceptor blocking drug (indoramin) in exercise-induced bronchoconstriction.
    Seale JP; Anderson SD; Lindsay DA
    Scand J Respir Dis; 1976; 57(6):261-6. PubMed ID: 189384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of dopamine receptors in vesicourethral function. A urodynamic study with dopamine receptor antagonist metoclopramide.
    Vaidyanathan S; Rao MS; Bapna BC; Chary KS; Swamy RP
    Ann Clin Res; 1980 Feb; 12(1):1-4. PubMed ID: 7377750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of urethral resistance at external sphincter zone during voiding by static withdrawal urethrometrogram.
    Miyagawa I
    Urol Int; 1984; 39(6):327-31. PubMed ID: 6084356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of indoramin added to oxprenolol and bendrofluazide as a third agent in severe hypertension.
    Marshall AJ; Kettle MA; Barritt DW
    Br J Clin Pharmacol; 1980 Sep; 10(3):217-21. PubMed ID: 7437237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antihypertensive therapy with indoramin in the elderly.
    Deitch MW; Allen IE; Pascucci VL
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S88-92. PubMed ID: 2423807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dissociation of urethral and anal sphincter activity in neurogenic bladder dysfunction.
    Nordling J; Meyhoff HH
    J Urol; 1979 Sep; 122(3):352-6. PubMed ID: 381690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement in angina pectoris with alpha adrenoceptor blockade.
    Collins P; Sheridan D
    Br Heart J; 1985 May; 53(5):488-92. PubMed ID: 2859870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urethral pressure profile during the spinal shock stage in man: a preliminary report.
    Awad SA; Bryniak SR; Downie JW; Twiddy DA
    J Urol; 1977 Jan; 117(1):91-3. PubMed ID: 318708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of autonomic dysreflexia with phenoxybenzamine.
    McGuire J; Wagner FM; Weiss RM
    J Urol; 1976 Jan; 115(1):53-5. PubMed ID: 1246113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional contribution of autonomic innervation to urethral striated sphincter: studies with parasympathomimetic, parasympatholytic and alpha-adrenergic blocking agents in spinal cord injury and control male subjects.
    Yalla SB; Rossier AB; Fam BA; Gabilondo FB; Di Benedetto M; Gittes RF
    J Urol; 1977 Apr; 117(4):494-9. PubMed ID: 850325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurogenic failures of the external urethral sphincter closure and relaxation; a videourodynamic study.
    Sakakibara R; Hattori T; Uchiyama T; Yamanishi T; Ito H; Ito K
    Auton Neurosci; 2001 Jan; 86(3):208-15. PubMed ID: 11270099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential of alpha blockade in treating human hypertension: a role for indoramin.
    Laragh JH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S37-42. PubMed ID: 2423795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropharmacologic evaluation in spinal cord injury patients using membrane catheter cystosphincterometry.
    Karol JB; Anderson RU
    J Urol; 1980 Sep; 124(3):395-6. PubMed ID: 7431506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vesicoureteral reflux and lower urinary tract dysfunction: evidence for 2 different reflux/dysfunction complexes.
    Griffiths DJ; Scholtmeijer RJ
    J Urol; 1987 Feb; 137(2):240-4. PubMed ID: 3806811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nicergoline in the treatment of neuropathic bladder dysfunction: a preliminary report.
    Gallego J; Forner V; Jimenez F; Martinez E
    Paraplegia; 1984 Aug; 22(4):216-24. PubMed ID: 6483464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antihypertensive therapy with indoramin: risk-benefit profile in clinical practice.
    Stannard M; Cohen M; Marrott PK; Pascucci VL
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S48-52. PubMed ID: 2423797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urethral afferent nerve activity affects the micturition reflex; implication for the relationship between stress incontinence and detrusor instability.
    Jung SY; Fraser MO; Ozawa H; Yokoyama O; Yoshiyama M; De Groat WC; Chancellor MB
    J Urol; 1999 Jul; 162(1):204-12. PubMed ID: 10379788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.